Alternatives to ONWARD Medical

Developing soft, stretchable brain-computer interface platforms.

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Developing lightweight bionic technology.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Developing wearable brain imaging systems using quantum sensing technology.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Revolutionizing electrophysiology with innovative, wireless, wearable Smart Skin technology for advanced monitoring.

Develops advanced robotic exoskeletons to assist individuals with mobility impairments.

Develops and commercializes minimally invasive robotic platforms for the neuroscience field.

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders like migraine and depression.

Multisensory belt using touch stimuli to help people regain normal walking sensations.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Developing a cortical visual prosthesis to restore functional vision for the severely blind.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).